varied the length of bear serum stimulation and the differentiation state of the MC3T3-E1cells. After stimulation in one of four conditions, RNA was isolated, and real-time PCRperformed as described in section 5.2.5. In each condition, three potential referencegenes (β-actin, ubiquitin, cyclophilin) and the geometric means [305] of the variouscombinations of reference genes were checked for seasonal trends by a single-factorANOVA for season, blocking by bear. The reference gene (or geometric mean) with thelowest magnitude of seasonal variation and the highest least significant number waschosen for normalization. Ubiquitin was later removed from reference gene analysis inall samples since it had a significant seasonal trend in one of the conditions.In the first condition, undifferentiated pre-osteoblasts (seeded the previous day)were stimulated in 2% seasonal bear serum for 3 hours. Since bear serum was collectedevery 10 days, several prehibernation, hibernation, and post-hibernation serum sampleswere available for each bear. Each well received only one serum sample, and the bearand date of collection were recorded. After 3 hours of stimulation, RNA was isolated.Real-time PCR was performed on BAD, Bcl-2, Cyclin D1, Per1, PTH1R, Runx2, Smurf1,and ubiquitin. Cyclophilin was used as a reference gene. In the second condition, aftercells were allowed to attach overnight, they were switched to differentiation media (α-MEM with 10% FBS, 50 μg/mL ascorbic acid and 10 mmol β-glycerophosphate) andgrown for 6 days, with a media change on the third day. Differentiating osteoblasts werethen stimulated in differentiation media supplemented with 2% seasonal bear serum for3 hours. Real-time PCR was performed on Akt, BAD, BAK, BAX, Bcl-XL, c-fos, MCSF,OCN, OPG, p53, Per1, TLR4, and ubiquitin. Samples were normalized to the geometricmean of 2 reference genes (β-actin and cyclophilin). In the third condition, after cellswere allowed to attach overnight, undifferentiated pre-osteoblasts were stimulated innormal growth media supplemented with 2% bear serum for 24 hours. Real-time PCRwas performed on ADRβ2, Akt, BAD, BAK, BAX, Bcl-2, Bcl-XL, BmalI, ColI, Cyclin D1,M-CSF, OCN, OPG, OPN, p53, Per1, Per2, PTH1R, RANKL, Runx2, Smurf1, TLR4, andubiquitin. Samples were normalized to the reference gene β-actin. In the fourthcondition, after cells were allowed to attach overnight, media was replaced withdifferentiation media containing 2% bear serum (instead of FBS). Cells were allowed todifferentiate in bear serum for 6 days, with a media change on day 3. Real-time PCRwas performed on BAD, BAX, Bcl-2, c-fos, ColI, Cyclin D1, OCN, OPG, OPN, Per1,94
PTH1R, RANKL, Runx2, Smurf1, TLR4, and ubiquitin. Cyclophilin was used as thereference gene.All statistical analyses were performed using JMP 7 software. Data werepresented as the LSM + SE. The units were relative since all samples were normalizedto reference genes and to a reference (FBS) sample. All available samples from allbears were grouped by season (i.e. prehibernation, hibernation, and post-hibernation)and analyzed with a single-factor ANOVA, blocking by bear, with a Tukey’s post-hoc.Graphs are represented with a point for each serum sample, and a smoothed averagecurve generated with JMP software by a cubic spline.6.3 ResultsIn the first condition (undifferentiated pre-osteoblasts stimulated for 3 hours inseasonal bear serum), there were no seasonal trends (Table 6.2). In the second study(differentiated osteoblasts stimulated for 3 hours in seasonal bear serum), ubiquitinexpression increased from 0.998+0.058 in osteoblasts cultured in prehibernation serumto 1.32+0.10 in osteoblasts cultured in post-hibernation serum (p=0.0341). Expression ofubiquitin in osteoblasts cultured in hibernation serum was not different from either activeseason (Table 6.3). In the third study (undifferentiated pre-osteoblasts stimulated for 24hours in seasonal bear serum) (Table 6.4), Akt expression increased from 0.796+0.102in cells cultured in hibernating bear serum to 1.55+0.182 in cells cultured in posthibernationserum; there was no significant difference in Akt gene expression in cellscultured in prehibernation bear serum compared to hibernation serum (p=0.0046).Cyclin D1 gene expression increased from 0.950+0.032 in cells cultured in hibernationserum to 1.12+0.05 in cells cultured in post-hibernation serum; Cyclin D1 expressionwas not different in cells cultured in prehibernation serum compared to those inhibernation nor post-hibernation serum (p=0.0177). In the fourth condition (differentiatedin bear serum for 6 days) (Table 6.5), expression of the markers for osteoblastdifferentiation Runx2 and OCN were upregulated in post-hibernation compared toprehibernation and hibernation seasons. Runx2 increased from 0.741+0.069 in cellscultured in hibernation serum to 1.13+0.12 in cells cultured in post-hibernation serum;Runx2 gene expression did not change in cells cultured in prehibernation serum95
- Page 1 and 2:
EXPLORATION OF THE ROLE OF SERUM FA
- Page 3 and 4:
Table of contentsIndex of Figures .
- Page 5 and 6:
Chapter Four - Attempts to find an
- Page 7 and 8:
Index of figures1.1. Simplified sch
- Page 9 and 10:
6.17. Longitudinal analysis of OPG
- Page 11 and 12:
6.49. Longitudinal analysis of ColI
- Page 13 and 14:
A.2. Complete list of BSALP correla
- Page 15 and 16:
List of abbreviationsα-MEM. Alpha-
- Page 17 and 18:
PCR. Polymerase chain reactionPer1
- Page 19 and 20:
G2/M checkpoint. The point in the c
- Page 21 and 22:
Species names13-lined ground squirr
- Page 23 and 24:
Chapter One - Background and signif
- Page 25 and 26:
1.3 Bone turnover is unbalanced dur
- Page 27 and 28:
pro-apoptosis regulator BAX. An imp
- Page 29 and 30:
low-dose administration of parathyr
- Page 31 and 32:
decrease in bone trabecular thickne
- Page 33 and 34:
experience periodic arousals in whi
- Page 35 and 36:
ears must have evolved a mechanism
- Page 37 and 38:
1.7.6 Hypothesis 2: OCN interacts w
- Page 39 and 40:
ain, heart, and femoral muscle of h
- Page 41 and 42:
Hypothesis 3a: Serum concentrations
- Page 44:
were released. Behavior indicating
- Page 47 and 48:
2.3 ResultsSerum activity of the bo
- Page 49 and 50:
(p
- Page 51 and 52:
post-hibernation sampling in the be
- Page 53 and 54:
also unclear whether ucOCN may affe
- Page 55 and 56:
atios of intact to fragmented OCN m
- Page 57 and 58:
Table 2.3—Bone marker “seasonal
- Page 59 and 60:
Table 2.7—Chemistry panel “seas
- Page 61 and 62:
ABNormalized BSALPBSALP (U/L)CO N D
- Page 63 and 64:
Total Calcium (mg/dL)A1.21.151.11.0
- Page 65 and 66: ABTotal OCN (ng/mL)150100500O N D J
- Page 67 and 68: Adiponectin (ng/mL)AB40003500300025
- Page 69 and 70: ABNormalized InsulinInsulin (μU/mL
- Page 71 and 72: surrounding and encompassing hibern
- Page 73 and 74: decreased from 788+30 ng/mL in preh
- Page 75 and 76: 120-122]. Most small hibernators ar
- Page 77 and 78: ears. Similarly, serum NPY increase
- Page 79 and 80: Table 3.2—Serum factor longitudin
- Page 81 and 82: Leptin (ng/mL)ABO N D J F M A M O N
- Page 83 and 84: Norepinephrine (ng/mL)A807060504030
- Page 85 and 86: IGF‐1 (ng/mL)AN D J F M A MB10009
- Page 87 and 88: 2008. Samples were collected as des
- Page 89 and 90: sampling points. It is possible to
- Page 91 and 92: C‐Terminal PTH (Relative)AB504030
- Page 93 and 94: Chapter Five — Serum from hiberna
- Page 95 and 96: Synergy HT Multi-Detection Micropla
- Page 97 and 98: gene specific primers and 12.5 μL
- Page 99 and 100: involved in the reduced caspase-3/7
- Page 101 and 102: hibernation cycles without problem
- Page 103 and 104: filtered seasonal bear serum and fo
- Page 105 and 106: which is dependent upon caspase-3 a
- Page 107 and 108: Caspase‐3/7 ActivityO N D J F M A
- Page 109 and 110: 6Caspase‐3/7 Activity54321**0Vehi
- Page 111 and 112: ABCaspase‐3/7 Activity9876543210*
- Page 113 and 114: eyond the G1/S checkpoint, thus ind
- Page 115: ears, it is possible that tissue se
- Page 119 and 120: factors Runx2 and OCN also increase
- Page 121 and 122: Table 6.3—Gene expression 3 hour
- Page 123 and 124: Table 6.5—Gene expression 6 day d
- Page 125 and 126: Cyclin D1 Gene ExpressionO N D J F
- Page 127 and 128: Smurf1 Gene ExpressionO N D J F M A
- Page 129 and 130: BAK Gene ExpressionO N D J F M A MM
- Page 131 and 132: M‐CSF Gene ExpressionO N D J F M
- Page 133 and 134: Per1 Gene ExpressionO N D J F M A M
- Page 135 and 136: Akt Gene ExpressionO N D J F M A MM
- Page 137 and 138: Bcl‐2 Gene ExpressionO N D J F M
- Page 139 and 140: Cyclin D1 Gene ExpressionO N D J F
- Page 141 and 142: OPN Gene ExpressionO N D J F M A MM
- Page 143 and 144: 2PTH1R Gene Expression1.510.50O N D
- Page 145 and 146: TLR4 Gene ExpressionO N D J F M A M
- Page 147 and 148: Bcl‐2 Gene ExpressionO N D J F M
- Page 149 and 150: OCN Gene ExpressionO N D J F M A MM
- Page 151 and 152: PTH1R Gene ExpressionO N D J F M A
- Page 153 and 154: TLR4 Gene ExpressionO N D J F M A M
- Page 155 and 156: condition in renal patients in whic
- Page 157 and 158: hibernation. This report brings to
- Page 159 and 160: 14. Kaneps, A.J., S.M. Stover, and
- Page 161 and 162: 41. Chowdhury, I., B. Tharakan, and
- Page 163 and 164: 68. Ashe, M.C., et al., Bone geomet
- Page 165 and 166: 95. Perrien, D.S., et al., Aging al
- Page 167 and 168:
122. Lesser, R.W., et al., Renal re
- Page 169 and 170:
151. Confavreux, C.B., R.L. Levine,
- Page 171 and 172:
178. Toribara, T.Y., A.R. Terepka,
- Page 173 and 174:
206. Luo, X.H., et al., Adiponectin
- Page 175 and 176:
233. Florant, G.L., et al., Fat-cel
- Page 177 and 178:
259. Bhasin, S., et al., Older men
- Page 179 and 180:
284. Miura, M., et al., A crucial r
- Page 181 and 182:
Appendix A—Complete tables of cor
- Page 183 and 184:
Table A.5—Complete list of ionize
- Page 185 and 186:
Table A.7—Complete list of adipon
- Page 187 and 188:
Table A.12—Complete list of norep